A randomised, controlled, phase 3 trial comparing levonorgestrel-releasing intrauterine system Donasert R (also known as Levosert R)with the reference product Mirena R for the alleviation of heavy menstrual bleeding
Latest Information Update: 16 Dec 2021
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Menorrhagia
- Focus Therapeutic Use
Most Recent Events
- 16 Dec 2021 New trial record
- 01 Dec 2021 Results published in the European Journal of Contraception and Reproductive Health Care